Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded
- Contract number
- SPE2DB26FWGBB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,478
Award facts
- Contract value 100% obligated
- $25,477.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,477.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Dupixent 200 mg/1.14 mL pens. This is a non-set-aside competitive award with a completion date of November 5, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a critical pharmaceutical distributor for federal medical procurement needs.
AmerisourceBergen Drug Corp, a major pharmaceutical and healthcare solutions provider, supplies a comprehensive range of medications and medical commodities to support military and veteran healthcare systems. The company's extensive federal contract portfolio with the DLA Medical Supply Chain demonstrates its capability to fulfill competitive procurements across multiple therapeutic domains, from specialty medications and brand-name drugs to vaccines and medical devices. This delivery order for Dupixent, a biologic medication used primarily for treating eczema, asthma, and other allergic conditions, reflects the company's role in ensuring the availability of critical pharmaceutical products across the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB26FWGBB?
SPE2DB26FWGBB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FWGBB worth?
The government has obligated $25,478 on SPE2DB26FWGBB.
Is contract SPE2DB26FWGBB an order under another contract?
Yes. SPE2DB26FWGBB is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB26FWGBB competed?
The extent of competition for SPE2DB26FWGBB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award